The 46 references in paper И. Зотова В., М. Исаева Ю., М. Алехин Н., Б. Сидоренко А., Д. Затейщиков А., И. Зотова В., М. Исаева Ю., М. Алехин Н., Б. Сидоренко А., Д. Затейщиков А. (2013) “ОЦЕНКА РИСКА ТРОМБОЭМБОЛИЙ ПРИ МЕРЦАТЕЛЬНОЙ АРИТМИИ: СОВРЕМЕННОЕ СОСТОЯНИЕ ПРОБЛЕМЫ” / spz:neicon:aterotromboz:y:2013:i:1:p:21-32

1
Bogousslavsky J., Cachin C., Regli F., Despland P. A., Van Melle G., Kappenberger L. Cardiac sources of embolism and cerebral infarction-clinical consequences and vascular concomitants: the lausanne stroke registry. Neurology. 1991; 41: 855–9.
(check this in PDF content)
2
Hart R., Halperin J. L. Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention. Ann Intern Med. 1999; 131:688–695, Hart RG, Palacio S, Pearce LA. Atrial fibrillation, Stroke, and acute Antithrombotic Therapy. Analysis of randomized clinical trials. Stroke. 2002; 33: 2722–27.
(check this in PDF content)
3
Рыкунов И. Е., Сандриков В. А., Буравихина Т. А. и др. Чреспищеводная эхокардиография в диагностике объемных образований сердца и паракардиального пространства. Кардиология 1996; 12: 95–101.
(check this in PDF content)
4
Исаева М. Ю., Зотова И. В., Алехин М. Н. и соавт. Выявление тромбоза ушка левого предсердия у больных с мерцательной аритмией и факторами риска развития тромбоэмболических осложнений: роль чреспищеводной эхокардиографии и мультиспиральной компьютерной томографии. Кардиология. 2007; 47 (5): 40–45.
(check this in PDF content)
5
Hart R. G., Pearce L. A., Aguilar M. I. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857–67.
(check this in PDF content)
6
Olesen J. B., Lip G. Y., Hansen M. L. et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 2011; 342: 124–32.
(check this in PDF content)
7
Friberg L., Rosenqvist M., Lip GYH. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J 2012; 33: 1500–10.
(check this in PDF content)
8
Friberg L., Benson L., Rosenqvist M., Lip GYH. Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study. BMJ 2012; 344: e3522–32.
(check this in PDF content)
9
Okuyama H., Hirono O., Liu L. et al. Higher Levels of Serum Fibrin-Monomer Reflect Hypercoagulable State and Thrombus Formation in the Left Atrial Appendage in Patients With Acute Ischemic. Circ J 2006; 70: 971–976.
(check this in PDF content)
10
Зотова И. В., Исаева М. Ю., Ваниева О. С. и др. Система гемостаза у больных с мерцательной аритмией: маркеры тромбоза ушка левого предсердия. Кардиология. 2008; 2: 36–40.
(check this in PDF content)
11
Habara S., Dote K., Kato M. et al. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. Eur Heart J 2007; 28: 2217–2222.
(check this in PDF content)
12
Sugiura S., Fujii E., Senga M. et al. Clinical features of patients with left atrial thrombus undergoing anticoagulant therapy. J Interv Card Electrophysiol 2012; 34: 59–63.
(check this in PDF content)
13
Sakai M., Hamamatsu A., Kuboki K. et al. Examinations to detect left atrial thrombus and blood coagulation test analyses in aged patients with atrial fibrillation. Japan J Geriatr 1994; 31: 447–455.
(check this in PDF content)
14
Roldan V., Marin F., Marco P. et al. Hypofibrinolysis in atrial fibrillation. Am Heart J 1998; 136: 956–960.
(check this in PDF content)
15
Conway D. S., Pearce L. A., Bernard S. et al. Prognostic Value of Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 994 Patients With Nonvalvular Atrial Fibrillation. Circulation 2003; 107: 3141–3145.
(check this in PDF content)
16
Fukuchi M., Watanabe J., Kumagai K. et al. Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage. J Am Coll Cardiol 2001; 37: 1436–1442.
(check this in PDF content)
17
Roldan V., Marin F., Muiсa B. et al. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. J Am Coll Cardiol 2011; 57: 2496–504.
(check this in PDF content)
18
Igarashi Y., Yamaura M., Ito M. et al. Elevated serum lipoprotein (a) is a risk factor for left atrial thrombus in patients with chronic atrial fibrillation: A transesophageal endocardiographic study. Am Heart J 1998; 136: 965–971.
(check this in PDF content)
19
Igarashi Y., Kasai H., Yamashita F. et al. Lipoprotein (a), left atrial appendage function and thromboembolic risk in patients with chronic nonvalvular atrial fibrillation. Japan Circ 2000; 64: 93–98.
(check this in PDF content)
20
Hijazi Z., Oldgren J., Andersson U. et al. Cardiac Biomarkers are Associated with an Increased Risk of Stroke and Death in Patients with Atrial Fibrillation: A RELY Substudy. Circulation 2012; 125: 1605–16.
(check this in PDF content)
21
Deftereos S., Giannopoulos G., Kossyvakis C. et al. Short-term fluctuations of plasma NT-proBNP levels in patients with new-onset atrial fibrillation: a way to assess time of onset? Heart 2010; 96: 1033–36.
(check this in PDF content)
22
Deftereos S., Giannopoulos G., Kossyvakis C. et al. Estimation of atrial fibrillation recency of onset and safety of cardioversion using NTproBNP levels in patients with unknown time of onset. Heart 2011; 97: 914–17.
(check this in PDF content)
23
Gokce M., Ucar F., Kucukosmanoglu M. et al. Factor V Leiden Mutation and Its Relation to Left Atrial Thrombus in Chronic Nonrheumatic Atrial Fibrillation. Jpn Heart J 2003; 44: 481–491.
(check this in PDF content)
24
Hatzinikolaou-Kotsakou E., Kartasis Z., Tziakas D. et al. Atrial fibrillation and hypercoagulability: dependent on clinical factors or/ and on genetic alterations? J Thromb Thrombolysis 2003; 16: 155–161.
(check this in PDF content)
25
Feinberg W. M., Pearce L. A., Hart R. G. et al. Markers of Thrombin and Platelet Activity in Patients With Atrial Fibrillation. Stroke 1999; 30: 2547–2553.
(check this in PDF content)
26
Berge E., Haug K., Sandset E. C. et al. The Factor V Leiden, Prothrombin Gene 20210GA, Methylenetetrahydrofolate Reductase 677CT and Platelet Glycoprotein IIIa 1565TC Mutations in Patients With Acute Ischemic Stroke and Atrial Fibrillation. Stroke 2007; 38: 1069–1071.
(check this in PDF content)
27
Go A. S., Reed G. L., Hylek E. M. et al. Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. J Thromb Thrombolys 2003; 15: 41–46.
(check this in PDF content)
28
Poli D., Antonucci E., Cecchi E. et al. Thrombophilic mutations in high-risk atrial fibrillation patients: high prevalence of prothrombin gene G20210A polymorphism and lack of correlation with thromboembolism. Thromb Haemost 2003; 90: 1158–1162.
(check this in PDF content)
29
Carter A. M., Catto A. J., Grant P. J. et al. Association of the alfa-Fibrinogen Thr312Ala Polymorphism With Poststroke Mortality in Subjects With Atrial Fibrillation. Circulation 1999; 99: 2423–2426.
(check this in PDF content)
30
Zotova I., Brovkin A., Isaeva M. et al. Factor V polymorphism associated with left atrial thrombosis in patients with nonvalvular atrial fibrillation. Atherosclerosis thrombosis and vascular biology annual conference. 2008. Atlanta, April 16– 18: 125.
(check this in PDF content)
31
Данковцева Е. Н., Затейщиков Д. А., Чудакова Д. А. и др. Полиморфизм генов факторов гемостаза у пациентов с ранним развитием ишемической болезни сердца. Кардиология 2005; 12: 17–24.
(check this in PDF content)
32
Di Biase L., Gaita F., Salvetti I. et al. Left atrial appendage morphology correlates with a reduced risk for stroke in patients with AF. Eur Heart J 2011; 32; 7: Abstract 133.
(check this in PDF content)
33
Xu J., Cui G., Esmailian F. et al. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation 2004; 109: 363–68.
(check this in PDF content)
34
Oakes R. S., Badger T. J., Kholmovski E. G. et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 2009; 119: 1758–67.
(check this in PDF content)
35
Mahnkopf C., Badger T. J., Burgon N. S. et al. Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation. Heart Rhythm 2010; 7: 1475–81.
(check this in PDF content)
36
Daccarett M., Badger T. J., Akoum N. et al. Association of left atrial fibrosis detected by delayedenhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. JACC 2011; 57: 831–8.
(check this in PDF content)
37
Manning W. J., Weintraub R. M., Wakmonski C. A. et al. Accuracy of transesophageal echocardiography for identifying left atrial thrombi: a prospective, intraoperative study. Ann Intern Med 1995; 123: 817–22.
(check this in PDF content)
38
Alizadeh A., Maleki M., Bassiri H. et al. Evaluation of atrial thrombus formation and atrial appendage function in patients with pacemaker by transesophageal echocardiography. Pacing Clin Electrophysiol 2006; 29 (11): 1251–54.
(check this in PDF content)
39
Schneider B., Stollberger C., Schneider B. et al. Diagnosis of Left Atrial Appendage Thrombi by Multiplane Transesophageal Echocardiography In terlaboratory Comparative Study. Circ J 2007; 71: 122–25.
(check this in PDF content)
40
Yoshida H., Tsunoda K., Yamada Z. et al. Evaluation of intracardiac thrombus with computed tomography. Am J Cardiol 1996; 51 (5): 843–52.
(check this in PDF content)
41
Martinez M. W., Kirsch J., Williamson E. E. et al. Utility of nongated multidetector computed tomography for detection of left atrial thrombus in patients undergoing catheter ablation of atrial fibrillation. JACC Cardiovasc Imaging 2009; 2: 69–76.
(check this in PDF content)
42
Singh N. K., Nallamothu N., Zuck V. P., Issa Z. F. Left atrial appendage filling defects on 64-slice multidetector computed tomography in patients undergoing pulmonary vein isolation: predictors and comparison to transesophageal echocardiography. J Comput Assist Tomogr 2009; 33: 946–51.
(check this in PDF content)
43
Kapa S., Martinez M. W., Williamson E. E. et al. ECG-gated dual-source CT for detection of left atrial appendage thrombus in patients undergoing catheter ablation for atrial fibrillation. J Interv Card Electrophysiol 2010; 29: 75–81.
(check this in PDF content)
44
Sawit S. T., Garcia-Alvarez A., Suri B. et al. Usefulness of cardiac computed tomographic delayed contrast enhancement of the left atrial appendage before pulmonary vein ablation. Am J Cardiol 2012; 109: 677–84.
(check this in PDF content)
45
Patel A., Au E., Donegan K. et al. Multidetector row computed tomography for identification of left atrial appendage filling defects in patients undergoing pulmonary vein isolation for treatment of atrial fibrillation: comparison with transesophageal echocardiography. Heart Rhythm 2008; 5: 253–60.
(check this in PDF content)
46
Gottlieb I., Pinheiro A., Brinker J. A. et al. Diagnostic accuracy of arterial phase 64-slice multidetector CT angiography for left atrial appendage thrombus in patients undergoing atrial fibrillation ablation. J Cardiovasc Electrophysiol 2008; 19: 247–51.
(check this in PDF content)